AIGH Capital Management LLC - Q2 2022 holdings

$380 Million is the total value of AIGH Capital Management LLC's 94 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 59.5% .

 Value Shares↓ Weighting
IWM BuyISHARES TRput$138,876,000
+32.4%
820,000
+60.5%
36.54%
+42.0%
DZSI BuyDZS INC$27,470,000
+26.3%
1,688,366
+7.7%
7.23%
+35.5%
ADTN BuyADTRAN INC$20,353,000
+10.5%
1,161,019
+16.2%
5.36%
+18.5%
AVEO BuyAVEO PHARMACEUTICALS INC$19,336,000
+22.7%
2,947,594
+4.5%
5.09%
+31.6%
CYBE  CYBEROPTICS CORP$17,817,000
-13.9%
509,9170.0%4.69%
-7.6%
TGAN NewTRANSPHORM INC$14,063,0003,778,937
+100.0%
3.70%
MTRN NewMATERION CORP$13,359,000181,189
+100.0%
3.52%
NewSONO GROUP N V$10,337,0003,516,129
+100.0%
2.72%
AVNW  AVIAT NETWORKS INC$10,214,000
-18.6%
407,9180.0%2.69%
-12.7%
CAMP BuyCALAMP CORP$9,745,000
-24.8%
2,336,942
+31.8%
2.56%
-19.3%
SIMO SellSILICON MOTION TECHNOLOGY COsponsored adr$9,575,000
-61.7%
114,400
-69.5%
2.52%
-59.0%
ANIP NewANI PHARMACEUTICALS INC$7,254,000244,500
+100.0%
1.91%
THTX SellTHERATECHNOLOGIES INC$7,007,000
-4.5%
2,913,067
-1.7%
1.84%
+2.5%
MRAM  EVERSPIN TECHNOLOGIES INC$6,729,000
-39.8%
1,284,2490.0%1.77%
-35.5%
PRTK BuyPARATEK PHARMACEUTICALS INC$6,537,000
-29.9%
3,387,172
+7.9%
1.72%
-24.8%
SCPH SellSCPHARMACEUTICALS INC$6,491,000
-18.2%
1,346,724
-3.6%
1.71%
-12.2%
AIRG NewAIRGAIN INC$5,907,000727,484
+100.0%
1.55%
ICAD NewICAD INC$5,442,0001,360,510
+100.0%
1.43%
SCYX  SCYNEXIS INC$4,163,000
-52.4%
2,238,1360.0%1.10%
-49.0%
BKTI  BK TECHNOLOGIES CORPORATION$3,640,000
+3.9%
1,373,7500.0%0.96%
+11.5%
RFIL  RF INDS LTD$3,175,000
-14.0%
512,0370.0%0.84%
-7.8%
MDNA  MEDICENNA THERAPEUTICS CORP$2,647,000
-8.9%
2,272,7000.0%0.70%
-2.4%
 IDEAL PWR INC$2,611,000
+39.1%
213,3680.0%0.69%
+49.3%
LPTH  LIGHTPATH TECHNOLOGIES INC$2,509,000
-37.6%
2,039,8320.0%0.66%
-33.1%
NewCOGNITION THERAPEUTICS INC$2,382,000910,790
+100.0%
0.63%
VCNX  VACCINEX INC$2,248,000
-14.4%
2,081,8010.0%0.59%
-8.1%
ARDX BuyARDELYX INC$2,226,000
-33.2%
3,773,421
+21.2%
0.59%
-28.3%
TELA NewTELA BIO INC$2,156,000306,464
+100.0%
0.57%
EOLS SellEVOLUS INC$2,002,000
-80.5%
172,592
-84.3%
0.53%
-79.0%
CLRB  CELLECTAR BIOSCIENCES INC$1,625,000
+28.7%
1,837,0460.0%0.43%
+38.1%
RNAZ NewTRANSCODE THERAPEUTICS INC$1,624,0001,289,000
+100.0%
0.43%
FKWL BuyFRANKLIN WIRELESS CORP$1,243,000
+215.5%
390,000
+294.6%
0.33%
+237.1%
NewCONTEXT THERAPEUTICS INC$1,188,0001,191,771
+100.0%
0.31%
SLNO SellSOLENO THERAPEUTICS INC$1,177,000
-22.4%
6,361,349
-6.5%
0.31%
-16.7%
NBSE  NEUBASE THERAPEUTICS INC$1,079,000
-44.2%
1,027,5850.0%0.28%
-40.1%
MYO  MYOMO INC$1,037,000
-55.9%
617,1790.0%0.27%
-52.7%
NewSAVERONE 2014 LTDsponsored ads$1,027,000449,100
+100.0%
0.27%
BW NewBABCOCK & WILCOX ENTERPRISES$984,000163,199
+100.0%
0.26%
XFOR  X4 PHARMACEUTICALS INC$962,000
-44.9%
997,7190.0%0.25%
-40.9%
PCSA  PROCESSA PHARMACEUTICALS INC$853,000
-6.8%
303,7030.0%0.22%0.0%
RZLT SellREZOLUTE INC$274,000
-80.7%
84,783
-79.9%
0.07%
-79.4%
BLIN SellBRIDGELINE DIGITAL INC$214,000
-83.0%
178,003
-73.1%
0.06%
-81.9%
NewSAVERONE 2014 LTDcall$200,000570,194
+100.0%
0.05%
OSMT NewRVL PHARMACEUTICALS PLC$116,00084,993
+100.0%
0.03%
NLSPW SellNLS PHARMACEUTICS LTDcall$99,000
-91.5%
827,421
-0.1%
0.03%
-90.9%
CYTHW SellCYCLO THERAPEUTICS INCcall$38,000
-95.9%
294,431
-0.2%
0.01%
-95.6%
NewPARABELLUM ACQUISITION CORPcall$38,000589,286
+100.0%
0.01%
AMPG ExitAMPLITECH GROUP INC$0-137,372
-100.0%
-0.11%
HSDT ExitHELIUS MED TECHNOLOGIES INC$0-255,400
-100.0%
-0.21%
ABEO ExitABEONA THERAPEUTICS INC$0-5,025,100
-100.0%
-0.39%
PDSB ExitPDS BIOTECHNOLOGY CORP$0-282,609
-100.0%
-0.43%
YTEN ExitYIELD10 BIOSCIENCE INC$0-343,685
-100.0%
-0.45%
WTT ExitWIRELESS TELECOM GROUP INC$0-1,872,639
-100.0%
-0.79%
EDAP ExitEDAP TMS S Asponsored adr$0-627,316
-100.0%
-1.12%
PLAB ExitPHOTRONICS INC$0-1,219,740
-100.0%
-5.08%
PDFS ExitPDF SOLUTIONS INC$0-859,812
-100.0%
-5.88%
INTC ExitINTEL CORPcall$0-511,000
-100.0%
-6.16%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AVIAT NETWORKS INC12Q3 20236.8%
SCPHARMACEUTICALS INC12Q3 20238.5%
THERATECHNOLOGIES INC11Q2 20232.9%
FRANKLIN WIRELESS CORP11Q3 20232.9%
IDEAL PWR INC11Q3 20232.5%
MEDICENNA THERAPEUTICS CORP11Q3 20231.1%
PARATEK PHARMACEUTICALS INC10Q1 20233.2%
LIGHTPATH TECHNOLOGIES INC10Q3 20233.0%
MYOMO INC10Q3 20231.3%
DZS INC9Q1 20237.5%

View AIGH Capital Management LLC's complete holdings history.

Latest significant ownerships (13-D/G)
AIGH Capital Management LLC Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Bridgeline Digital, Inc.May 21, 2021627,4199.7%

View AIGH Capital Management LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-15
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-12
13F-HR2022-02-10
13F-HR2021-11-12

View AIGH Capital Management LLC's complete filings history.

Compare quarters

Export AIGH Capital Management LLC's holdings